J B Hermiller
Overview
Explore the profile of J B Hermiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaff M, Hadley G, Hermiller J, Simonton C, Hinohara T, Cannon L, et al.
Catheter Cardiovasc Interv
. 2006 Oct;
68(5):684-9.
PMID: 17039509
Background: The StarClose Vascular Closure System (Abbott Vascular, Redwood City, CA) features a nitinol clip that is designed to achieve closure of the femoral arteriotomy access site. The CLIP Study...
2.
Hermiller J, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M, et al.
Catheter Cardiovasc Interv
. 2006 Oct;
68(5):677-83.
PMID: 17039508
Background: The StarClose Vascular Closure System is a femoral access site closure technology that uses a flexible nitinol clip to complete a circumferential, extravascular arteriotomy close. The Clip CLosure In...
3.
Lederman R, Tenaglia A, Anderson R, Hermiller J, Rocha-Singh K, Mendelsohn F, et al.
Am J Cardiol
. 2001 Jul;
88(2):192-5, A6-7.
PMID: 11448424
The Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 for Intermittent Claudication (TRAFFIC) is a large, randomized, placebo-controlled, regimen-finding trial of intra-arterial recombinant fibroblast growth factor-2 in patients with intermittent claudication....
4.
Baim D, Cutlip D, OShaughnessy C, Hermiller J, Kereiakes D, Giambartolomei A, et al.
Am J Cardiol
. 2001 Jan;
87(2):152-6.
PMID: 11152830
The NIR stent is a novel second generation tubular stent that was designed to overcome some of the limitations of the earlier Palmaz-Schatz (PS) stent design. The NIR Vascular Advanced...
5.
Davidson C, Laskey W, Hermiller J, Harrison J, Matthai Jr W, Vlietstra R, et al.
Circulation
. 2000 May;
101(18):2172-7.
PMID: 10801758
Background: Previous in vitro and in vivo studies have suggested an association between thrombus-related events and type of contrast media. Low osmolar contrast agents appear to improve the safety of...
6.
Madan M, Kereiakes D, Hermiller J, Rund M, Tudor G, Anderson L, et al.
Am J Cardiol
. 2000 Mar;
85(4):435-40.
PMID: 10728946
Abciximab, an Fab monoclonal antibody fragment that blocks the platelet glycoprotein IIb/IIIa receptor, is increasingly used as an adjunct to coronary intervention. Little is known, however, about the efficacy and...
7.
Fry E, Hermiller J, Pinkerton C
Curr Opin Cardiol
. 1999 Mar;
13(4):232-9.
PMID: 10091018
Intracoronary stenting improves the acute and long-term safety and efficacy of percutaneous coronary interventions by minimizing the risks of abrupt closure and late restenosis. Enhanced designs of new coronary stents...
8.
Timmis S, Hermiller J, BURNS W, Meyers S, Davidson C
Am J Cardiol
. 1999 Mar;
83(3):311-6.
PMID: 10072214
Angiographic studies have demonstrated that perfusion balloon percutaneous transluminal coronary angioplasty (PTCA) may result in modestly improved luminal gains and fewer major dissections than conventional balloon PTCA. However, intracoronary ultrasound...
9.
Timmis S, Burns W, Hermiller J, Parker M, Meyers S, Davidson C
Am Heart J
. 1998 Jan;
134(6):1099-106.
PMID: 9424071
Objectives: Intracoronary ultrasonography was used to assess coronary arteries before and after balloon percutaneous transluminal coronary angioplasty (PTCA) to determine whether the mode of coronary atherosclerotic remodeling affects the mechanism...
10.
Nasser T, Fry E, Annan K, Khatib Y, Peters T, VanTassel J, et al.
Am J Cardiol
. 1997 Nov;
80(8):998-1001.
PMID: 9352967
We studied 1,238 patients receiving 1,880 coronary stents. In-hospital outcomes were divided by age into <65 years (n = 747, group 1), 65 to 75 years (n = 326, group...